Document:

Exhibit 10.2

 

GENIUS BRANDS INTERNATIONAL, INC.

2020 INCENTIVE PLAN

 

STOCK OPTION GRANT NOTICE

 

Genius Brands International,
Inc. (the “Company”), pursuant to its 2020 Incentive Plan (the “Plan”), hereby grants
to Optionholder an option to purchase the number of shares of the Company’s Common Stock set forth below. This option is subject
to all of the terms and conditions as set forth herein and in the Option Agreement, the Plan, and the Notice of Exercise, all of which
are attached hereto and incorporated herein in their entirety.

 

	Optionholder:	Zrinka Dekic
	Date of Grant:	December 9, 2021
	Vesting Commencement Date:	Date of Grant
	Number of Shares Subject to Option:	250,000
	Exercise Price (Per Share):	$1.20
	Expiration Date:	10th anniversary of Date
of Grant

 

	Type of Grant:	☐ Incentive Stock Option	☒ Nonstatutory Stock Option
	 	 	 
	Exercise Schedule:	☒
Same as Vesting Schedule	 

 

Vesting Schedule: This Nonstatutory Stock Option shall be vested and exercisable as follows, subject to the
Optionholder’s continued employment with the Company through such date:

 

		·	83,333 Shares subject to the Nonstatutory Stock Option shall be vested and exercisable on the first anniversary
of the Date of Grant;

		·	83,333 Shares subject to the Nonstatutory Stock Option shall be vested and exercisable on the second anniversary
of the Date of Grant;

		·	83,334 Shares subject to the Nonstatutory Stock Option shall be vested and exercisable on the third anniversary
of the Date of Grant;

 

	Payment:	By one or a combination of the following
items (described in the Option Agreement):

 

		·	By cash, check bank draft or money order payable to the Company

		·	Pursuant to a Regulation T Program if the shares are publicly traded

		·	Subject to the Company’s consent at the time of exercise, by delivery of already-owned shares

		·	Subject to the Company’s consent at the time of exercise, by a “net exercise” arrangement

 

Additional Terms/Acknowledgements: The
undersigned Optionholder acknowledges receipt of, and understands and agrees to, this Stock Option Grant Notice, the Option Agreement
and the Plan. Optionholder further acknowledges that as of the Date of Grant, this Stock Option Grant Notice, the Option Agreement, and
the Plan set forth the entire understanding between Optionholder and the Company regarding the acquisition of stock in the Company and
supersede all prior oral and written agreements on that subject with the exception of (i) options previously granted and delivered to
Optionholder under the Plan, and (ii) the following agreements only:

 

 

 

    	 	1	 

     

    

 

OTHER AGREEMENTS: That certain Employment
Agreement, by and between the Optionholder and the Company, effective as of December 13, 2021 (the “Employment Agreement”).

 

	GENIUS BRANDS INTERNATIONAL, INC.	OPTIONHOLDER:
	 	 
	By: __________________________________________	By: __________________________________________
	Signature	Signature
	 	 
	Title: CEO	Date: December 9, 2021
	 	 
	Date: December 9, 2021	 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	2	 

     

    

 

GENIUS BRANDS INTERNATIONAL, INC.

2020 INCENTIVE PLAN

 

STOCK OPTION GRANT AGREEMENT

 

(NONSTATUTORY STOCK OPTION)

 

Pursuant to your Stock Option
Grant Notice (“Grant Notice”), that certain Employment Agreement, by and between the Optionholder and the Company,
effective as of December 13, 2021 (the “Employment Agreement”), and this Option Agreement, Genius Brands International,
Inc. (the “Company”) has granted you an option under its 2020 Incentive Plan (the “Plan”)
to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in
your Grant Notice. Defined terms not explicitly defined in this Option Agreement but defined in the Plan shall have the same definitions
as in the Plan.

 

The details of your option are as follows:

1. Vesting.

 

(a)            
Subject to the limitations contained herein and to Section 1(b) hereof, your option will vest as provided in your Grant Notice, provided that vesting will cease upon the termination of your employment or service
with the Company.

 

(b)            
All unvested options shall accelerate and become fully vested upon the termination of your employment or service with the Company
by the Company without Cause or your resignation for Good Reason. For purposes of this Agreement, “Cause” shall have the
meaning set forth in the Employment Agreement, by and between you and the Company, effective as of December 13, 2021 (the “Employment
Agreement”). For purposes of this Agreement, “Good Reason” shall mean following events or conditions: (i) a reduction
by the Company in your Base Salary or Target Bonus (each, as defined in the Employment Agreement) level; (ii) a requirement that you
work at a location more than fifty (50) miles away from your place of work as of the Grant Date; (iii) the assignment to you by the Company
of duties substantially inconsistent with role and duties as Chief Financial Officer and Head of Strategy and Mergers and Acquisitions,
any change in your titles or the significant reduction of the powers and functions associated with, your positions, titles or offices;
(iv) the failure of any successor (whether direct or indirect, by stock or asset purchase, merger, consolidation or otherwise) to all
or substantially all of the business and/or assets of the Company to expressly to assume and agree to perform the Employment Agreement
in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place; or
(v) any requirement that you report to someone other than the Chief Executive Officer of the Company. Any assertion by you of a termination
for Good Reason shall not be effective unless all of the following conditions are satisfied: (A) the condition described in Sections
1(b)(i), 1(b)(ii), 1(b)(iii), 1(b)(iv) or 1(b)(v) giving rise to your termination of employment must have arisen without your consent;
(B) you must provide written notice to the Board of the existence of such condition(s) within thirty (30) days of the initial existence
of such condition(s); (C) the condition(s) specified in such notice must remain uncorrected for thirty (30) days following the Board’s
receipt of such written notice; and (D) the date of your termination of employment must occur within sixty (60) days after the initial
existence of the condition(s) specified in such notice.

 

2. Number Of Shares and
Exercise Price. The number of shares of Common Stock subject to your option and your exercise price per share referenced in your
Grant Notice may be adjusted from time to time for Capitalization Adjustments.

 

3. Exercise Restriction
For Non-Exempt Employees. In the event that you are an Employee eligible for overtime compensation under the Fair Labor Standards
Act of 1938, as amended (i.e., a “Non-Exempt Employee”), you may not exercise your option until you have completed
at least six (6) months of employment or service with the Company measured from the Date of Grant specified in your Grant Notice, notwithstanding
any other provision of your option.

 

 

 

    	 	3	 

     

    

 

4. Method Of Payment. Payment
of the exercise price is due in full upon exercise of all or any part of your option. You may elect to make payment of the exercise price
in cash or by check or in any other manner permitted by your Grant Notice, subject to the following:

 

(a)  
Bank draft or money order payable to the Company.

 

(b)  
Provided that at the time of exercise the Common Stock is publicly traded and quoted regularly in The Wall Street Journal,
pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of Common Stock,
results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise
price to the Company from the sales proceeds.

 

(c)  
Subject to the consent of the Company at the time of exercise, by delivery to the Company (either by actual delivery or attestation)
of already-owned shares of Common Stock that are owned free and clear of any liens, claims, encumbrances or security interests, and that
are valued at Fair Market Value on the date of exercise. Notwithstanding the foregoing, you may not exercise your option by tender to
the Company of Common Stock to the extent such tender would violate the provisions of any law, regulation or agreement restricting the
redemption of the Company’s stock.

 

(d)  
If the Option is a Nonstatutory Stock Option, subject to the consent of the Company at the time of exercise, by a “net
exercise” arrangement pursuant to which the Company will reduce the number of shares of Common Stock issued upon exercise of
your option by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; provided,
however, that the Company shall accept a cash or other payment from you to the extent of any remaining balance of the aggregate exercise
price not satisfied by such reduction in the number of whole shares to be issued; provided further, however, that shares of Common Stock
will no longer be outstanding under your option and will not be exercisable thereafter to the extent that (1) shares are used to pay the
exercise price pursuant to the “net exercise,” (2) shares are delivered to you as a result of such exercise, and (3)
shares are withheld to satisfy tax withholding obligations.

 

5. Whole Shares.
You may exercise your option only for whole shares of Common Stock.

 

6. Securities
Law Compliance. Notwithstanding anything to the contrary contained herein, you may not exercise your option unless the shares
of Common Stock issuable upon such exercise are then registered under the Securities Act of 1933 (the “Securities Act”)
or, if such shares of Common Stock are not then so registered, the Company has determined that such exercise and issuance would be exempt
from the registration requirements of the Securities Act. The exercise of your option also must comply with other applicable laws and
regulations governing your option, and you may not exercise your option if the Company determines that such exercise would not be in
material compliance with such laws and regulations.

 

7. Term.
You may not exercise your option before the commencement or after the expiration of its term. The term of your option commences on the
Date of Grant and expires upon the earliest of the following:

 

(a)  
three (3) months after the termination of your employment or service with the Company for any reason other than your Disability
or death, provided that if during any part of such three (3)-month period you may not exercise your option solely because of the condition
set forth in the preceding paragraph relating to “Securities Law Compliance,” your option shall not expire until the
earlier of the Expiration Date or until it shall have been exercisable for an aggregate period of three (3) months after the termination
of your employment or service with the Company;

 

 

 

    	 	4	 

     

    

 

(b)  
twelve (12) months after the termination of your employment or service with the Company due to your Disability;

 

(c)  
twelve (12) months after your death if you die either during your employment or service with the Company or within three (3) months
after your employment or service with the Company terminates;

 

(d)  
immediately upon the termination of your employment or service with the Company in the event of Cause (as defined in the Employment
Agreement) or upon your violation of any of Sections 8.1, 8.3 or 8.5 of the Employment Agreement; or

 

(e)  
the Expiration Date indicated in your Grant Notice.

 

If your option is an Incentive
Stock Option, note that, to obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that
at all times beginning on the date of grant of your option and ending on the day three (3) months before the date of your option’s
exercise, you must be an employee of the Company or an Affiliate, except in the event of your death or Disability. The Company has provided
for extended exercisability of your option under certain circumstances for your benefit but cannot guarantee that your option will necessarily
be treated as an Incentive Stock Option if you continue to provide services to the Company or an Affiliate as a Consultant or Director
after your employment terminates or if you otherwise exercise your option more than three (3) months after the date your employment terminates.

 

8. Exercise.

 

(a) You may exercise
the vested portion of your option during its term by delivering a Notice of Exercise (in a form designated by the Company) together with
the exercise price to the Secretary of the Company, or to such other person as the Company may designate, during regular business hours,
together with such additional documents as the Company may then require.

 

(b) By
exercising your option you agree that, as a condition to any exercise of your option, the Company may require you to enter into an
arrangement providing for the payment by you to the Company of any tax withholding obligation of the Company arising by reason of
(1) the exercise of your option, (2) the lapse of any substantial risk of forfeiture to which the shares of Common Stock are subject
at the time of exercise, or (3) the disposition of shares of Common Stock acquired upon such exercise.

 

(c) If your option
is an Incentive Stock Option, by exercising your option you agree that you will notify the Company in writing within fifteen (15) days
after the date of any disposition of any of the shares of the Common Stock issued upon exercise of your option that occurs within two
(2) years after the date of your option grant or within one (1) year after such shares of Common Stock are transferred upon exercise of
your option.

 

9. Transferability.

 

(a) Restrictions
on Transfer. Your option shall not be transferable except by will or by the laws of descent and distribution and shall be exercisable
during your lifetime only by you; provided, however, that the Board may, in its sole discretion, permit transfer of your
options in a manner that is not prohibited by applicable tax and securities laws upon your request.

 

(b) Domestic
Relations Orders. Notwithstanding the foregoing, your option may be transferred pursuant to a domestic relations order;
provided, however, that if your option is an Incentive Stock Option, your option shall be deemed to be a Nonstatutory Stock Option
as a result of such transfer.

 

(c) Beneficiary
Designation. Notwithstanding the foregoing, you may, by delivering written notice to the Company, in a form provided by or otherwise
satisfactory to the Company and any broker designated by the Company to effect option exercises, designate a third party who, in the event
of your death, shall thereafter be entitled to exercise your option. In the absence of such a designation, the executor or administrator
of your estate shall be entitled to exercise your option.

 

 

 

    	 	5	 

     

    

 

10. Option Not A Service
Contract. Your option is not an employment or service contract, and nothing in your option shall be deemed to create in any way
whatsoever any obligation on your part to continue in the employ of the Company or an Affiliate, or of the Company or an Affiliate to
continue your employment. In addition, nothing in your option shall obligate the Company or an Affiliate, their respective stockholders,
Boards of Directors, Officers or Employees to continue any relationship that you might have as a Director or Consultant for the Company
or an Affiliate.

 

11. Withholding Obligations.

 

(a)   At the time
you exercise your option, in whole or in part, or at any time thereafter as requested by the Company, you hereby authorize withholding
from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for (including by means of a “cashless
exercise” pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board to the extent permitted
by the Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or an
Affiliate, if any, which arise in connection with the exercise of your option.

 

(b)  
Upon your request and subject to approval by the Company, in its sole discretion, and compliance with any applicable legal conditions
or restrictions, the Company may withhold from fully vested shares of Common Stock otherwise issuable to you upon the exercise of your
option a number of whole shares of Common Stock having a Fair Market Value, determined by the Company as of the date of exercise, not
in excess of the minimum amount of tax required to be withheld by law (or such lower amount as may be necessary to avoid classification
of your option as a liability for financial accounting purposes). If the date of determination of any tax withholding obligation is deferred
to a date later than the date of exercise of your option, share withholding pursuant to the preceding sentence shall not be permitted
unless you make a proper and timely election under Section 83(b) of the Code, covering the aggregate number of shares of Common Stock
acquired upon such exercise with respect to which such determination is otherwise deferred, to accelerate the determination of such tax
withholding obligation to the date of exercise of your option. Notwithstanding the filing of such election, shares of Common Stock shall
be withheld solely from fully vested shares of Common Stock determined as of the date of exercise of your option that are otherwise issuable
to you upon such exercise. Any adverse consequences to you arising in connection with such share withholding procedure shall be your sole
responsibility.

 

(c)  
You may not exercise your option unless the tax withholding obligations of the Company and/or any Affiliate are satisfied. Accordingly,
you may not be able to exercise your option when desired even though your option is vested, and the Company shall have no obligation to
issue a certificate for such shares of Common Stock or release such shares of Common Stock from any escrow provided for herein unless
such obligations are satisfied.

 

12. 
Tax Consequences. You hereby agree that the Company does not have a duty to design or administer the Plan or its other
compensation programs in a manner that minimizes your tax liabilities. You shall not make any claim against the Company, or any of its
Officers, Directors, Employees or Affiliates related to tax liabilities arising from your option or your other compensation. In particular,
you acknowledge that this option is designed to be exempt from Section 409A of the Code only if the exercise price per share specified
in the Grant Notice is at least equal to the “fair market value” per share of the Common Stock on the Date of Grant
and there is no other impermissible deferral of compensation associated with the option.

 

13. 
Notices. Any notices provided for in your option or the Plan shall be given in writing and shall be deemed effectively
given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5) days after deposit in the United States
mail, postage prepaid, addressed to you at the last address you provided to the Company.

 

14. 
Governing Plan Document. Your option is subject to all the provisions of the Plan, the provisions of which are hereby
made a part of your option, and is further subject to all interpretations, amendments, rules and regulations, which may from time to
time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the provisions of your option and those of
the Plan, the provisions of the Plan shall control.

 

 

 

    	 	6	 

     

    

 

15. 
Entire Agreement; Amendment. This Agreement, together with the Plan, and the Employment Agreement contains
the entire agreement between the parties hereto with respect to the subject matter contained herein, and supersedes all prior agreements
or prior understandings, whether written or oral, between the parties relating to such subject matter. The Committee shall have the right,
in its sole discretion, to modify or amend this Agreement from time to time in accordance with and as provided in the Plan. This Agreement
may also be modified or amended by a writing signed by both the Company and you. The Company shall give you written notice of any such
modification or amendment of this Agreement as soon as practicable after the adoption thereof.

 

16. 
Governing Law. All questions concerning the construction, validity and interpretation of this Agreement shall be governed
by, and construed in accordance with, the laws of the State of Nevada, without regard to the choice of law principles thereof.

 

17. 
Transfer of Personal Data. You authorize, agree and unambiguously consent to the transmission by the Company (or any
Subsidiary) of any personal data information related to the Nonqualified Stock Option awarded under this Agreement for legitimate business
purposes (including, without limitation, the administration of the Plan). This authorization and consent is freely given by you.

 

18. 
Compliance with Laws. The grant of Nonqualified Stock Options and the issuance of shares of Common Stock hereunder shall
be subject to, and shall comply with, any applicable requirements of any foreign and U.S. federal and state securities laws, rules and
regulations (including, without limitation, the provisions of the Securities Act, the Exchange Act and in each case any respective rules
and regulations promulgated thereunder) and any other law, rule regulation or exchange requirement applicable thereto. The Company shall
not be obligated to issue the Nonqualified Stock Option or any shares of Common Stock pursuant to this Agreement if any such issuance
would violate any such requirements. As a condition to the exercise of the Nonqualified Stock Option, the Company may require you to satisfy
any qualifications that may be necessary or appropriate to evidence compliance with any applicable law or regulation.

 

19. 
Binding Agreement; Assignment. This Agreement shall inure to the benefit of, be binding upon, and be enforceable by
the Company and its successors and assigns. You shall not assign any part of this Agreement without the prior express written consent
of the Company.

 

20. 
Headings. The titles and headings of the various sections of this Agreement have been inserted for convenience of reference
only and shall not be deemed to be a part of this Agreement.

 

21. 
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original,
but all of which shall constitute one and the same instrument.

 

22. 
Further Assurances. Each party hereto shall do and perform (or shall cause to be done and performed) all such further
acts and shall execute and deliver all such other agreements, certificates, instruments and documents as either party hereto reasonably
may request in order to carry out the intent and accomplish the purposes of this Agreement and the Plan and the consummation of the transactions
contemplated thereunder.

 

23. 
Severability. The invalidity or unenforceability of any provisions of this Agreement in any jurisdiction shall not affect
the validity, legality or enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality or enforceability
of any provision of this Agreement in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder
shall be enforceable to the fullest extent permitted by law.

 

24. 
Acquired Rights. You acknowledge and agree that: (a) the Company may terminate or amend the Plan at any time; (b) Nonqualified
Stock Options granted under this Agreement is completely independent of any other award or grant and is made at the sole discretion of
the Company; (c) no past grants or awards (including, without limitation, the Nonqualified Stock Options awarded hereunder) give you any
right to any grants or awards in the future whatsoever; and (d) any benefits granted under this Agreement are not part of your ordinary
salary, and shall not be considered as part of such salary in the event of severance, redundancy or resignation.

 

 

 

    	 	7	 

     

    

 

NOTICE OF EXERCISE

GENIUS BRANDS INTERNATIONAL

190 N. CANON DRIVE, FL #4

BEVERLY HILLS, CA 90210

Date of Exercise:                     

 

Ladies and Gentlemen:

 

This constitutes
notice under my stock option that I elect to purchase the number of shares for the price set forth below.

 

	Type of option (check one):	Incentive ☐	Nonstatutory ☐
	Stock option dated:	 	 
	Number of shares as to which option is exercised:	 	 
	Certificates to be issued in name of:	 	 
	Total exercise price:	$_______________	 
	Cash or check delivered herewith:	$_______________	 
	Regulation T Program (cashless exercise)	$_______________	 
	Value of _____ shares of Genius Brands International, Inc.

      common stock delivered herewith:1
	$_______________	 
	Value of _____ shares of Genius Brands International, Inc.

      common stock pursuant to net exercise:2
	$_______________	 

 

		1	Subject to the consent of Genius Brands International, Inc. at the time of exercise. Shares of Common
Stock must be valued in accordance with the terms of the option being exercised, must have been owned for the minimum period required
in the option, and must be owned free and clear of any liens, claims, encumbrances or security interests. Certificates must be endorsed
or accompanied by an executed assignment separate from certificate.

 

		2	Genius Brands International, Inc. must have established net exercise procedures at the time of exercise
in order to utilize this payment method and must expressly consent to your use of net exercise at the time of exercise. An Incentive Stock
Option may not be exercised by a net exercise arrangement.

 

By this exercise,
I agree (i) to provide such additional documents as you may require pursuant to the terms of the 2020 Incentive Plan, (ii) to provide
for the payment by me to you (in the manner designated by you) of your withholding obligation, if any, relating to the exercise of this
option, and (iii) if this exercise relates to an incentive stock option, to notify you in writing within fifteen (15) days after the date
of any disposition of any of the shares of Common Stock issued upon exercise of this option that occurs within two (2) years after the
date of grant of this option or within one (1) year after such shares of Common Stock are issued upon exercise of this option.

 

 

Very truly yours,

 

_____________________________________________

 

 

 

    	 	8Exhibit
4.3

 

THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT
EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING [●] (THE “EFFECTIVE DATE”)
TO ANYONE OTHER THAN (I) BOUSTEAD SECURITIES, LLC OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING FOR WHICH THIS PURCHASE WARRANT
WAS ISSUED TO THE UNDERWRITER AS CONSIDERATION (THE “OFFERING”), OR (II) AN OFFICER, PARTNER, REGISTERED PERSON OR AFFILIATE
OF BOUSTEAD SECURITIES, LLC.

 

THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO __________, 202____. VOID AFTER 5:00 P.M., EASTERN TIME, DECEMBER __, 2026.

 

FORM
OF COMMON STOCK PURCHASE WARRANT

 

For
the Purchase of [●] Shares of Common Stock

of

Cerberus
Cyber Sentinel Corporation

 

1.
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Boustead Securities, LLC (“Holder”),
as registered owner of this Purchase Warrant, to Cerberus Cyber Sentinel Corporation, a Delaware corporation (the “Company”),
Holder is entitled, at any time or from time to time beginning December ___, 2021 (the “Commencement Date”), and at
or before 5:00 p.m., Eastern time, December ____, 2026 (the “Expiration Date”), but not thereafter, to subscribe for,
purchase and receive, in whole or in part, up to [●] shares of common stock of the Company, par value $0.00001 per share (the “Shares”),
subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions in New York are
authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance
with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate
this Purchase Warrant. This Purchase Warrant is initially exercisable at $ [●] per Share; provided, however,
that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the
exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term
“Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

 

2.
Exercise.

 

2.1
Exercise Form. In order to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed and completed
and delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Shares being purchased payable
in cash by wire transfer of immediately available funds to an account designated by the Company or by certified check or official bank
check. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date,
this Purchase Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease and expire.
Each exercise hereof shall be irrevocable.

 

2.2
Cashless Exercise. In lieu of exercising this Purchase Warrant by payment of cash or check payable to the order of the Company
pursuant to Section 2.1 above, Holder may elect to receive the number of Shares equal to the value of this Purchase Warrant (or the portion
thereof being exercised), by surrender of this Purchase Warrant to the Company, together with the exercise form attached hereto, in which
event the Company will issue to Holder Shares in accordance with the following formula:

 

	X	=	Y(A-B)	 
	A	 

Where,

	 	X	=	The number of Shares to be issued to Holder;
	 	Y	=	The number of Shares for which the Purchase Warrant is being exercised;
	 	A	=	The Trading Value on the trading day immediately preceding the date of the applicable exercise notice; and
	 	B	=	The Exercise Price.

 

    	 

    	 

    

 

For
purposes of this Section 2.2, the fair market value of a Share is defined as follows:

 

	 	(i)	if the Company’s
    common stock is traded on a national securities exchange, the OTCQB or OTCQX, the value shall be deemed to be the VWAP on such exchange,
    the OTCQB or OTCQX, as the case may be, on the Business Day immediately preceding the date that the exercise form is delivered pursuant
    to Section 8.4 in connection with the exercise of the Purchase Warrant; or

 

	 	(ii)	if the Company’s
    common stock is not then traded on a national securities exchange, the OTCQB or OTCQX, and if prices for the Company’s common
    stock are then reported on the “Pink Sheets” published by OTC Markets Group, Inc., the value shall be deemed to be the
    closing bid prior to the exercise form being submitted in connection with the exercise of the Purchase Warrant so reported; provided,
    however, if there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the
    Company’s Board of Directors.

 

For
purposes of this Section 2.2,

 

Trading
Value means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
on a national securities exchange (an “Eligible Market”), the value shall be deemed to be the highest intra-day or closing
price on any trading day on such Eligible Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)) during the five trading days preceding the exercise,
(b) if the Common Stock is not listed on an Eligible Market, the value shall be deemed to be the highest intra-day or closing price on
any trading day on the OTCQB or OTCQX on which the Common Stock is then quoted as reported by Bloomberg L.P. (based on a trading day
from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)) during the five trading days preceding the exercise, as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions
of reporting prices, the “OTC Markets Group”) the value shall be deemed to be the highest intra-day or closing price on any
trading day on the Pink Sheets as reported by OTC Markets Group (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m.
(New York City time)) during the five trading days preceding the exercise, or (d) in all other cases, the fair market value of a share
of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company.

 

2.3
Legend. Each certificate for the securities purchased under this Purchase Warrant shall bear a legend as follows unless such securities
have been registered under the Securities Act of 1933, as amended (the “Act”):

 

“The
securities represented by this certificate have not been registered under the Securities Act of 1933, as amended (the “Act”),
or applicable state law. Neither the securities nor any interest therein may be offered for sale, sold or otherwise transferred except
pursuant to an effective registration statement under the Act, or pursuant to an exemption from registration under the Act and applicable
state law which, in the opinion of counsel to the Company, is available.”

 

2.4
Resale of Shares. Holder and the Company acknowledge that as of the date hereof the Staff of the Division of Corporation Finance
of the SEC has published Compliance & Disclosure Interpretation 528.04 in the Securities Act Rules section thereof, stating that
the holder of securities issued in connection with a public offering may not rely upon Rule 144 promulgated under the Act to establish
an exemption from registration requirements under Section 4(a)(1) under the Act, but may nonetheless apply Rule 144 constructively for
the resale of such shares in the following manner: (a) provided that six months has elapsed since the last sale under the registration
statement, an underwriter or finder may resell the securities in accordance with the provisions of Rule 144(c), (e), and (f), except
for the notice requirement; (b) a purchaser of the shares from an underwriter receives restricted securities unless the sale is made
with an appropriate, current prospectus, or unless the sale is made pursuant to the conditions contained in (a) above; (c) a purchaser
of the shares from an underwriter who receives restricted securities may include the underwriter’s holding period, provided that
the underwriter or finder is not an affiliate of the issuer; and (d) if an underwriter transfers the shares to its employees, the employees
may tack the firm’s holding period for purposes of Rule 144(d), but they must aggregate sales of the distributed shares with those
of other employees, as well as those of the underwriter or finder, for a six-month period from the date of the transfer to the employees.
Holder and the Company also acknowledge that the Staff of the Division of Corporation Finance of the SEC has advised in various no-action
letters that the holding period associated with securities issued without registration to a service provider commences upon the completion
of the services, which the Company agrees and acknowledges shall be the final closing of the Offering, and that Rule 144(d)(3)(ii) provides
that securities acquired from the issuer solely in exchange for other securities of the same issuer shall be deemed to have been acquired
at the same time as the securities surrendered for conversion (which the Company agrees is the date of the initial issuance of this Purchase
Warrant). In the event that following a reasonably-timed written request by Holder to transfer the Shares in accordance with Compliance
& Disclosure Interpretation 528.04 counsel for the Company in good faith concludes that Compliance & Disclosure Interpretation
528.04 no longer may be relied upon as a result of changes in applicable laws, regulations, or interpretations of the SEC Division of
Corporation Finance, or as a result of judicial interpretations not known by the Company or its counsel on the date hereof (either, a
“Registration Trigger Event”), then the Company shall promptly, and in any event within five (5) business days following
the request, provide written notice to Holder of such determination. As a condition to giving such notice, the parties shall negotiate
in good faith a single demand registration right pursuant to an agreement in customary form reasonably acceptable to the parties; provided
that notwithstanding anything to the contrary, the obligations of the Company pursuant to this Section 2 shall terminate on the fifth
anniversary of the Effective Date. In the absence of such conclusion by counsel for the Company, the Company shall, upon such a request
of Holder given no earlier than six months after the final closing of the Offering, instruct its transfer agent to permit the transfer
of such shares in accordance with Compliance & Disclosure Interpretation 528.04, provided that Holder has provided such documentation
as shall be reasonably requested by the Company to establish compliance with the conditions of Compliance & Disclosure Interpretation
528.04. Notwithstanding anything to the contrary, pursuant to FINRA Rule 5110(g)(8)(B)-(D), the Holder shall not be entitled to more
than one demand registration right hereunder and the duration of the registration rights hereunder shall not exceed five years from the
Effective Date.

 

    	2

    	 

    

 

3.
Transfer.

 

3.1
General Restrictions. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder
will not: (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant for a period of one hundred eighty (180) days following
the Effective Date to anyone other than: (i) Boustead Securities LLC (“Boustead”) or an underwriter, placement agent,
or a selected dealer participating in the Offering, or (ii) an officer, partner, registered person or affiliate of Boustead or of any
such underwriter, placement agent or selected dealer, in each case in accordance with FINRA Conduct Rule 5110(e)(1), or (b) cause this
Purchase Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction
that would result in the effective economic disposition of this Purchase Warrant or the securities hereunder, except as provided for
in FINRA Rule 5110(e)(2). After 180 days after the Effective Date, transfers to others may be made subject to compliance with or exemptions
from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to the Company the assignment form
attached hereto duly executed and completed, together with the Purchase Warrant and payment of all transfer taxes, if any, payable in
connection therewith. The Company shall within five (5) Business Days transfer this Purchase Warrant on the books of the Company and
shall execute and deliver a new Purchase Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing
the right to purchase the aggregate number of Shares purchasable hereunder or such portion of such number as shall be contemplated by
any such assignment.

 

3.2
Restrictions Imposed by the Act. The securities evidenced by this Purchase Warrant shall not be transferred unless and until:
(i) if required by applicable law, the Company has received the opinion of counsel for the Company that the securities may be transferred
pursuant to an exemption from registration under the Act and applicable state securities laws, or (ii) a registration statement or a
post-effective amendment to the Registration Statement relating to the offer and sale of such securities has been filed by the Company
and declared effective by the U.S. Securities and Exchange Commission (the “Commission”) and compliance with applicable
state securities law has been established.

 

4.
Piggyback Registration Rights.

 

4.1
Grant of Right. Whenever the Company proposes to register any shares of its common stock under the Act (other than (i) a registration
effected solely to implement an employee benefit plan or a transaction to which Rule 145 of the Act is applicable, or (ii) a registration
statement on Form S-4, S-8 or any successor form thereto or another form not available for registering the Shares issuable upon exercise
of this Purchase Warrant for sale to the public, whether for its own account or for the account of one or more stockholders of the Company
(a “Piggyback Registration”), the Company shall give prompt written notice (in any event no later than ten (10) Business
Days prior to the filing of such registration statement) to the Holder of the Company’s intention to effect such a registration
and, subject to the remaining provisions of this Section 4.1, shall include in such registration such number of Shares underlying this
Purchase Warrant (the “Registrable Securities”) that the Holders have (within ten (10) Business Days of the respective
Holder’s receipt of such notice) requested in writing (including such number) to be included within such registration. If a Piggyback
Registration is an underwritten offering and the managing underwriter advises the Company that it has determined in good faith that marketing
factors require a limit on the number of shares of common stock to be included in such registration, including all Shares issuable upon
exercise of this Purchase Warrant (if the Holder has elected to include such shares in such Piggyback Registration) and all other shares
of common stock proposed to be included in such underwritten offering, the Company shall include in such registration (i) first, the
number of shares of common stock that the Company proposes to sell and (ii) second, the number of shares of common stock, if any, requested
to be included therein by selling stockholders (including the Holder) allocated pro rata among all such persons on the basis of the number
of shares of common stock then owned by each such person or issuable upon exercise of this Purchase Warrant. If any Piggyback Registration
is initiated as a primary underwritten offering on behalf of the Company, the Company shall select the investment banking firm or firms
to act as the managing underwriter or underwriters in connection with such offering. Notwithstanding anything to the contrary, the obligations
of the Company pursuant to this Section 4.1 shall terminate on the earlier of (i) the fifth anniversary of the Effective Date and (ii)
the date that Rule 144 would allow the Holder to sell its Registrable Securities during any ninety (90) day period.

 

    	3

    	 

    

 

4.2
Indemnification. The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration
statement hereunder and each person, if any, who controls such Holders within the meaning of Section 15 of the Act or Section 20(a) of
the Securities Exchange Act of 1934, as amended (“Exchange Act”), against all loss, claim, damage, expense or liability
(including all reasonable attorneys’ fees and other out-of-pocket expenses reasonably incurred in investigating, preparing or defending
against any claim whatsoever) to which any of them may become subject under the Act, the Exchange Act or otherwise, arising from such
registration statement but only to the same extent and with the same effect as the provisions pursuant to which the Company has agreed
to indemnify Boustead contained in the Underwriting Agreement between Boustead and the Company, dated as of [●]. The Holder(s)
of the Registrable Securities to be sold pursuant to such registration statement, and their successors and assigns, shall severally,
and not jointly, indemnify the Company, against all loss, claim, damage, expense or liability (including all reasonable attorneys’
fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which they may
become subject under the Act, the Exchange Act or otherwise, arising from information furnished by or on behalf of such Holders, or their
successors or assigns, in writing, for specific inclusion in, or omission from, such registration statement to the same extent and with
the same effect as the provisions contained in the Underwriting Agreement pursuant to which Boustead has agreed to indemnify the Company.

 

4.3
Exercise of Purchase Warrants. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise
their Purchase Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.

 

4.4
Documents Delivered to Holders. The Company shall deliver promptly to each Holder participating in the offering requesting the
correspondence and memoranda described below, copies of all correspondence between the Commission and the Company, its counsel or auditors
and all memoranda relating to discussions with the Commission or its staff with respect to the registration statement and permit each
Holder and underwriter to do such investigation, upon reasonable advance notice, with respect to information contained in or omitted
from the registration statement as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation
shall include access to books, records and properties and opportunities to discuss the business of the Company with its officers and
independent auditors, all to such reasonable extent and at such reasonable times, during normal business hours, as any such Holder shall
reasonably request.

 

4.5
Underwriting Agreement. The Holders shall be parties to any underwriting agreement relating to a Piggyback Registration. Such
Holders shall not be required to make any representations or warranties to or agreements with the Company or the underwriters except
as they may relate to such Holders, their Shares and the amount and nature of their ownership thereof and their intended methods of distribution.

 

4.6
Documents to be Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish to
the Company a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security
holders.

 

4.7
Damages. Should the Company fail to comply with such provisions, the Holder(s) shall, in addition to any other legal or other
relief available to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive) relief against
the threatened breach of such provisions or the continuation of any such breach, without the necessity of proving actual damages and
without the necessity of posting bond or other security.

 

5.
New Purchase Warrants to be Issued.

 

5.1
Partial Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised or assigned
in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for cancellation,
together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax if exercised
pursuant to Section 2.1 hereto, the Company shall cause to be delivered to the Holder without charge a new Purchase Warrant of like tenor
to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to purchase the number of Shares purchasable hereunder
as to which this Purchase Warrant has not been exercised or assigned.

 

5.2
Lost Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of
this Purchase Warrant and of reasonably satisfactory indemnification or the posting of a bond, determined in the sole discretion of the
Company, the Company shall execute and deliver a new Purchase Warrant of like tenor and date. Any such new Purchase Warrant executed
and delivered as a result of such loss, theft, mutilation or destruction shall constitute a substitute contractual obligation on the
part of the Company.

 

    	4

    	 

    

 

6.
Adjustments.

 

6.1
Adjustments to Exercise Price and Number of Securities. The Exercise Price and the number of Shares underlying the Purchase Warrant
shall be subject to adjustment from time to time as hereinafter set forth:

 

6.1.1
Share Dividends; Split Ups. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding
Shares is increased by a stock dividend payable in Shares or by a split up of Shares or other similar event, then, on the effective day
thereof, the number of Shares purchasable hereunder shall be increased in proportion to such increase in outstanding Shares, and the
Exercise Price shall be proportionately decreased.

 

6.1.2
Aggregation of Shares. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding
Shares is decreased by a consolidation, combination or reclassification of Shares or other similar event, then, on the effective date
thereof, the number of Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding Shares, and the
Exercise Price shall be proportionately increased.

 

6.1.3
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Shares
other than a change covered by Section 6.1.1 or 6.1.2 hereof or that solely affects the par value of such Shares, or in the case of any
share reconstruction or amalgamation or consolidation or merger of the Company with or into another corporation (other than a consolidation
or share reconstruction or amalgamation or merger in which the Company is the continuing corporation and that does not result in any
reclassification or reorganization of the outstanding Shares), or in the case of any sale or conveyance to another corporation or entity
of the property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the
Holder of this Purchase Warrant shall have the right thereafter (until the expiration of the right of exercise of this Purchase Warrant)
to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder immediately prior to such event, the kind
and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization,
share reconstruction or amalgamation, or consolidation, or upon a dissolution following any such sale or transfer, by a Holder of the
number of Shares of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such event; and if any reclassification
also results in a change in Shares covered by Section 6.1.1 or 6.1.2, then such adjustment shall be made pursuant to Sections 6.1.1,
6.1.2 and this Section 6.1.3. The provisions of this Section 6.1.3 shall similarly apply to successive reclassifications, reorganizations,
share reconstructions or amalgamations, or consolidations, sales or other transfers.

 

6.1.4
Changes in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to this
Section 6.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Shares as are stated
in the Purchase Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of new Purchase Warrants
reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the Commencement
Date or the computation thereof.

 

6.2
Substitute Purchase Warrant. In case of any consolidation of the Company with, or share reconstruction or amalgamation or merger
of the Company with or into, another corporation (other than a consolidation or share reconstruction or amalgamation or merger which
does not result in any reclassification or change of the outstanding Shares), the corporation formed by such consolidation or share reconstruction
or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder of each Purchase Warrant
then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant) to receive,
upon exercise of such Purchase Warrant, the kind and amount of shares of stock and other securities and property receivable upon such
consolidation or share reconstruction or amalgamation, by a holder of the number of Shares of the Company for which such Purchase Warrant
might have been exercised immediately prior to such consolidation, share reconstruction or amalgamation or merger, sale or transfer.
Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to the adjustments provided for in this Section
6. The above provision of this Section shall similarly apply to successive consolidations or share reconstructions or amalgamations or
mergers.

 

6.3
Elimination of Fractional Interests. The Company shall not be required to issue certificates representing fractions of Shares
upon the exercise of the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it
being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction up or down, as the case may
be, to the nearest whole number of Shares or other securities, properties or rights.

 

7.
Reservation. The Company shall at all times reserve and keep available out of its authorized Shares, solely for the purpose of
issuance upon exercise of the Purchase Warrants, such number of Shares or other securities, properties or rights as shall be issuable
upon the exercise thereof. The Company covenants and agrees that, upon exercise of the Purchase Warrants and payment of the Exercise
Price therefor, in accordance with the terms hereby, all Shares and other securities issuable upon such exercise shall be duly and validly
issued, fully paid and non-assessable and not subject to preemptive rights of any shareholder.

 

    	5

    	 

    

 

8.
Certain Notice Requirements.

 

8.1
Holder’s Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or
consent or to receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as
a shareholder of the Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the
events described in Section 8.2 shall occur, then, in one or more of said events, the Company shall deliver to each Holder a copy of
each notice relating to such events given to the other shareholders of the Company at the same time and in the same manner that such
notice is given to the shareholders.

 

8.2
Events Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more of the
following events: (i) if the Company shall take a record of the holders of its Shares for the purpose of entitling them to receive a
dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings,
as indicated by the accounting treatment of such dividend or distribution on the books of the Company, or (ii) the Company shall offer
to all the holders of its Shares any additional shares of capital stock of the Company or securities convertible into or exchangeable
for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor.

 

8.3
Notice of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant
to Section 6 hereof, send notice to the Holders of such event and change (“Price Notice”). The Price Notice shall
describe the event causing the change and the method of calculating same.

 

8.4
Transmittal of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing
and shall be deemed to have been duly made when hand delivered, or mailed by express mail or private courier service: (i) if to the registered
Holder of the Purchase Warrant, to the address of such Holder as shown on the books of the Company, or (ii) if to the Company, to following
address or to such other address as the Company may designate by notice to the Holders:

 

If
to the Holder:

 

Boustead
Securities, LLC

6
Venture, Suite 265

Irvine,
CA 92618

Attention:
Chief Executive Officer

 

with
a copy (which shall not constitute notice) to:

 

Michelman
& Robinson LLP

800
Third Avenue, 24th Floor

New
York, NY 10022

Attn:
Megan J. Penick

 

If
to the Company:

 

Cerberus
Cyber Sentinel Corporation

6900
E Camelback Road, Suite 240

Scottsdale,
Arizona 85251

Attn:
David G. Jemmett, Chief Executive Officer

 

with
a copy (which shall not constitute notice) to:

 

Gray
Reed & McGraw LLP

1601
Elm Street, Suite 6400

Dallas,
Texas 75201

Attn:
David R. Earhart, Partner

 

9.
Miscellaneous.

 

9.1
Amendments. The Company and Boustead may from time to time supplement or amend this Purchase Warrant without the approval of any
of the Holders in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent
with any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company
and Boustead may deem necessary or desirable and that the Company and Boustead deem shall not adversely affect the interest of the Holders.
All other modifications or amendments shall require the written consent of and be signed by (i) the Company and (ii) the Holder(s) of
Purchase Warrants then-exercisable for at least a majority of the Shares then-exercisable pursuant to all then-outstanding Purchase Warrants.

 

    	6

    	 

    

 

9.2
Headings. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or
affect the meaning or interpretation of any of the terms or provisions of this Purchase Warrant.

 

9.3.
Entire Agreement. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection
with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and supersedes
all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

 

9.4
Binding Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company
and their permitted assignees, respective successors, legal representative and assigns, and no other person shall have or be construed
to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions
herein contained.

 

9.5
Governing Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed and enforced
in accordance with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby
agrees that any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought
and enforced in the courts located in Los Angeles, California, or in the United States District Court located in Los Angeles, California,
and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such
exclusive jurisdiction and that such courts represent an inconvenient forum. Any process or summons to be served upon the Company may
be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it
at the address set forth in Section 8 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company
in any action, proceeding or claim. The Company and the Holder agree that the prevailing party(ies) in any such action shall be entitled
to recover from the other party(ies) all of its reasonable attorneys’ fees and expenses relating to such action or proceeding and/or
incurred in connection with the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf
of its stockholders and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and
all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.

 

9.6
Waiver, etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall
not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any
provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No
waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set
forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver
of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach,
non-compliance or non-fulfillment.

 

9.7
Exchange Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that,
at any time prior to the complete exercise of this Purchase Warrant by Holder, if the Company and Boustead enter into an agreement (“Exchange
Agreement”) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash or
a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

[Signature
Page Follows]

 

    	7

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the ___ day of December,
2021.

 

	 	Cerberus
    Cyber Sentinel Corporation	 
	 	 	 	 
	 	By:	 	 
	 	Name:	David
    G. Jemmett	 
	 	Title:	Chief
Executive Officer	 

 

    	8

    	 

    

 

[Form
to be used to exercise Purchase Warrant]

 

Date:
__________, 20___

 

The
undersigned hereby elects irrevocably to exercise the Purchase Warrant for ______ shares of common stock, par value $0.00001 per share
(the “Shares”), of Cerberus Cyber Sentinel Corporation, a Delaware corporation (the “Company”),
and hereby makes payment of $____ (at the rate of $____ per Share) in payment of the Exercise Price pursuant thereto. Please issue the
Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a new Purchase
Warrant representing the number of Shares for which this Purchase Warrant has not been exercised.

 

or

 

The
undersigned hereby elects irrevocably to convert its right to purchase ___ Shares of the Company under the Purchase Warrant for ______
Shares, as determined in accordance with the following formula:

 

	 	X	=	Y(A-B)	 
	A	 

	Where,	 	 	 
	 	X	=	The number of Shares to be issued to Holder;
	 	Y	=	The number of Shares for which the Purchase Warrant is being exercised;
	 	A	=	The VWAP of the trading day immediately preceding the date of the applicable exercise notice; and
	 	B	=	The Exercise Price which is equal to $[●] per share

 

The
undersigned agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company.

 

Please
issue the Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a
new Purchase Warrant representing the number of Shares for which this Purchase Warrant has not been converted.

 

Signature________________________________________________

 

Signature
Guaranteed ______________________________________

 

    	9

    	 

    

 

INSTRUCTIONS
FOR REGISTRATION OF SECURITIES

 

	Name:
    	 	 
	 	(Print
    in Block Letters)	 
	 	 	 
	Address:	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

NOTICE:
The signature to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement
or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership
on a registered national securities exchange.

 

    	10

    	 

    

 

[Form
to be used to assign Purchase Warrant]

 

ASSIGNMENT

 

(To
be executed by the registered Holder to effect a transfer of the within Purchase Warrant):

 

FOR
VALUE RECEIVED, __________________ does hereby sell, assign and transfer unto the right to purchase shares of Common Stock, par value
$0.00001 per share, of Cereberus Cyber Sentinel Corporation, a Delaware corporation (the “Company”), evidenced by
the Purchase Warrant and does hereby authorize the Company to transfer such right on the books of the Company.

 

Dated:
__________, 20__

 

Signature
______________________________________________________

 

Signature
Guaranteed_____________________________________________

 

NOTICE:
The signature to this form must correspond with the name as written upon the face of the within Purchase Warrant without alteration or
enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm
having membership on a registered national securities exchange.

 

    	11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]